Targeted Therapeutics: Patrick Lu on Sirnaomics' Innovations in RNA Interference for Critical Diseases | Patrick Y. Lu , CEO, Sirnaomics Ltd. 00:10:00

Share On Facebook Share On Twitter

Patrick Y. Lu founded and has led Sirnaomics from an early discovery startup to a siRNA therapeutics product company, with multiple programs currently at the clinical stage. Dr. Lu brings 25+ years of nucleic acid drug development experience at Novartis, Digene, and Intradigm, where he was a co-founder.

Recent Videos